What are the common symptoms and potential side effects of a cortisone (corticosteroid) shot in the hip for an adult patient over 40 years old with a history of hip pain or inflammation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Symptoms and Side Effects of Hip Cortisone Injections

Hip corticosteroid injections commonly cause injection-site soreness, facial flushing/sweating, and transient pain exacerbation, with most side effects being mild and self-limited. 1

Immediate and Early Side Effects (Within Hours to Days)

Most Common Reactions

  • Injection-site soreness is the most frequently reported delayed adverse event, occurring in approximately 13% of patients 1
  • Vasovagal reactions (lightheadedness, fainting) occur in approximately 2.5% of patients during or immediately after the procedure 1
  • Facial flushing and/or sweating are corticosteroid-specific side effects that occur in a small percentage of patients (approximately 2% based on sacroiliac joint data) 1

Pain-Related Reactions

  • Post-injection pain flare can occur, with approximately 5% of patients experiencing pain exacerbations in the days following injection 1
  • Pain typically increases temporarily before improvement occurs 1
  • Average duration of meaningful pain relief is relatively short, approximately 6.7 weeks, though this varies considerably between patients 2

Systemic Corticosteroid Effects

Metabolic Effects

  • Transient hyperglycemia is a significant concern, particularly in diabetic patients, with blood glucose levels typically increasing during days 1-3 post-injection 1
  • Patients with diabetes should monitor glucose levels closely during this period 1

Endocrine Effects

  • Development of cushingoid features with repeated injections 3
  • Menstrual irregularities in women 3
  • Suppression of the hypothalamic-pituitary-adrenal axis with chronic use 1

Musculoskeletal Concerns

Joint-Specific Risks

  • Aseptic necrosis of the femoral head is a rare but serious complication listed in FDA labeling 3
  • Potential cartilage changes with repeated injections, though clinical significance remains uncertain 1
  • Charcot-like arthropathy with chronic use 3

Bone Health

  • Decreased bone mineral density with possible increased fracture risk with repeated injections 1
  • Osteoporosis development with long-term or repeated use 3

Rare but Serious Complications

Infectious Risks

  • Joint infection is extremely rare but documented in case reports 1
  • Immunosuppression increases infection susceptibility generally 1, 3
  • Risk is higher in immunocompromised patients 1

Neurologic Events

  • Transient sciatic nerve block can occur if the injection penetrates the anterior hip capsule, creating fall risk 1
  • This is more common when local anesthetic is included in the injectate 1

Cardiovascular and Other Systemic Effects

  • Hypertension, fluid retention, and hypokalemic alkalosis are possible 3
  • Bradycardia, cardiac arrhythmias (especially in patients on digitalis) 3
  • Thromboembolism risk 3

Important Clinical Considerations

Timing Relative to Surgery

  • Corticosteroid injections should be avoided within 3 months of planned hip replacement surgery due to potential increased infection risk (from 0.5% to 1.0%) 1

Duration of Benefit

  • Most patients experience limited long-term benefit, with only 37% reporting clinically significant pain reduction at 14 days and only 6% at 6 weeks 4
  • Mean duration of relief is approximately 9.8 days in patients with hip pathology 4

Gastrointestinal Effects

  • Increased risk of peptic ulcer disease, particularly when combined with NSAIDs 3
  • Nausea and abdominal distention 3

Dermatologic Reactions

  • Skin atrophy at injection site 3
  • Hyperpigmentation or hypopigmentation 3
  • Impaired wound healing 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.